Michael Graham, MD
Pediatric Hematology-Oncology · Las Vegas, NVNPI 1164496923
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $756 of the $1,034 with a category attached, or 73.1%. 13 manufacturers reported payments, led by Novo Nordisk at 28.6% of the total. Reporting peaked in 2020 at $339 and has fallen 84.1% since, to $54 in 2025.
Across 45 payments — averaging $22.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$296
- Genentech USA, Inc.$120
- Takeda Pharmaceuticals U.S.A., Inc.$103
- Sanofi$92
- CSL Behring$88
- Pfizer$79
- plus $256 from 7 others
What the payments were for
- Food & beverage$75673%
- Education$27927%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $296 |
| Genentech USA, Inc. | 5 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $103 |
| Sanofi | 4 | $92 |
| CSL Behring | 4 | $88 |
| Pfizer | 4 | $79 |
| Octapharma USA, Inc. | 2 | $74 |
| Bayer | 3 | $64 |
| Grifols USA, LLC | 2 | $33 |
| Emmaus Medical, Inc. | 4 | $28 |
| IBSA Pharma Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Biogen | 1 | $13 |
How this compares
Too few pediatric hematology-oncology providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pediatric hematology-oncology in Las Vegas
- Daisy CortesLas Vegas$385K
- Jenny Gober McDanielLas Vegas$43K
- Aimee FoordLas Vegas$41K
- Nik Nik Abdul RashidLas Vegas$32K
- Joseph LaskyLas Vegas$16K
- Jerry ReevesLas Vegas$12K
- Waseem AlhushkiLas Vegas$3K
- Alan IkedaLas Vegas$1K
- Sumit GuptaLas Vegas$1K
- Raul Montiel-EsparzaLas Vegas$794
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.